EZZ Life Science Holdings (ASX:EZZ) Market Cap: A$22.58 Mil (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EZZ EZZ Life Science Holdings Ltd ASX:EZZ
49 GF Score
Price A$0.48
GF Value A$1.45
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is EZZ Life Science Holdings Market Cap?

EZZ Life Science Holdings ASX:EZZ +3.23% 49 Market Cap is A$22.58 Mil as of Aug. 01, 2026. GuruFocus rates ASX:EZZ with a GF Score™ of 49/100 and a GF Value™ of A$1.45 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,422 Biotechnology companies, EZZ Life Science Holdings ranks worse than 79.4% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). EZZ Life Science Holdings's share price for the quarter that ended in Dec. 2025 was A$1.41. EZZ Life Science Holdings's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 47.07 Mil. Therefore, EZZ Life Science Holdings's market cap for the quarter that ended in Dec. 2025 was A$66.37 Mil.

EZZ Life Science Holdings's quarterly market cap declined from Dec. 2024 (A$144.82 Mil) to Jun. 2025 (A$110.38 Mil) and declined from Jun. 2025 (A$110.38 Mil) to Dec. 2025 (A$66.37 Mil).

EZZ Life Science Holdings's annual market cap increased from Jun. 2023 (A$21.35 Mil) to Jun. 2024 (A$81.94 Mil) and increased from Jun. 2024 (A$81.94 Mil) to Jun. 2025 (A$110.38 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. EZZ Life Science Holdings's Enterprise Value for Today is A$9.23 Mil.


EZZ Life Science Holdings  (ASX:EZZ) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


EZZ Life Science Holdings Market Cap Related Terms


EZZ Life Science Holdings Market Cap Historical Data

* Premium members only.

The historical data trend for EZZ Life Science Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EZZ Life Science Holdings Market Cap Chart

EZZ Life Science Holdings Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Market Cap
Get a 7-Day Free Trial 18.69 13.26 21.35 81.94 110.38

EZZ Life Science Holdings Semi-Annual Data
Jun20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 27.76 81.94 144.82 110.38 66.37

ASX:EZZ vs VRTX, REGN, RVMD: Market Cap Comparison

For the Biotechnology subindustry, EZZ Life Science Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EZZ Life Science Holdings Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's Market Cap falls into.


ASX:EZZ
49GF Score
EZZ Life Science Holdings Ltd ASX:EZZ
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EZZ Life Science Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

EZZ Life Science Holdings's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as

Market Cap (A: Jun. 2025 )=Share Price (A: Jun. 2025 )*Shares Outstanding (EOP) (A: Jun. 2025 )
=A$2.34*47.173
=A$110.38

EZZ Life Science Holdings's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=A$1.41*47.068
=A$66.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of A$22.58 Mil mean?
EZZ Life Science Holdings (ASX:EZZ) has a Market Cap of A$22.58 Mil as of Aug. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on EZZ Life Science Holdings and its competitors. According to the industry distribution chart, EZZ Life Science Holdings ranks #1129 out of 1422 companies in the Biotechnology industry, placing it in the top 79.4%.
Is EZZ Life Science Holdings' Market Cap too high?
EZZ Life Science Holdings' current Market Cap is A$22.58 Mil. Based on the distribution chart, EZZ Life Science Holdings ranks #1129 out of 1422 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, EZZ Life Science Holdings has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does EZZ Life Science Holdings' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, EZZ Life Science Holdings ranks #1129 out of 1422 companies for Market Cap. This places EZZ Life Science Holdings in the lower half of its industry. The industry median Market Cap is 109.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 109.62, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on EZZ Life Science Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 109.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EZZ Life Science Holdings's current Market Cap is A$22.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EZZ Life Science Holdings stock overvalued right now?
Based on GuruFocus' analysis, EZZ Life Science Holdings (ASX:EZZ) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.45, compared to a current price of A$0.48 — trading 66.9% below its estimated fair value. The current Market Cap is A$22.58 Mil. EZZ Life Science Holdings' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For EZZ Life Science Holdings (ASX:EZZ), the current Market Cap is A$22.58 Mil as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EZZ Life Science Holdings (ASX:EZZ) Overvalued in 2026?

Based on GuruFocus' analysis, EZZ Life Science Holdings stock appears to be undervalued. The current stock price of A$0.48 is trading 66.9% below its estimated GF Value™ of A$1.45. GuruFocus considers EZZ Life Science Holdings to be Possible Value Trap.

Key valuation signals for ASX:EZZ:

  • Market Cap: A$22.58 Mil
  • GF Value™: A$1.45 vs. price of A$0.48 (66.9% below fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the ASX:EZZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EZZ Life Science Holdings Business Description

Address 55-59 Parramatta Road, Shop 1, Lidcombe, NSW, AUS, 2141
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.
49GF Score

Get the complete analysis for ASX:EZZ

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.48
Price
A$1.45
GF Value